MedPage Today on MSN
Inhaled Vasodilator Slows Lung Function Decline in Idiopathic Pulmonary Fibrosis
Clinical worsening also occurred less frequently with treprostinil ...
A new human lung ageing atlas reveals cell-specific changes, mutation buildup, and declining lung repair capacity linked to ...
The Pulmonary Fibrosis Foundation's Care Center Network has grown to include 96 sites in 40 states as part of its first expansion since 2023, marking a milestone in strengthening access to ...
Background Pulmonary fibrosis (PF) caused by interstitial lung diseases (ILDs) affects up to 0.1% of the global population. There is growing global interest in PF, evident from a nearly threefold ...
Aging is associated with increased risk for nearly every lung disease, including acute conditions like pneumonia and chronic diseases like chronic obstructive pulmonary disease, idiopathic pulmonary ...
Researchers at Tulane University have identified a potential new way to treat idiopathic pulmonary fibrosis (IPF), a deadly and currently incurable lung disease that affects more than 3 million people ...
Lungs Double lung transplantation appears to offer superior survival outcomes to single lung transplantation in patients with interstitial pulmonary fibrosis who are younger than 70 years. Individuals ...
Baseimmune unveils a new multi-pathway immunotherapy strategy, applying its computational protein design platform to develop next-generation therapies for fibrosis. Fibrosis is driven by complex and ...
The doctor’s words hit Paul Rivera hard. This wasn’t just a cold; he had pulmonary fibrosis, a progressive condition where the lungs become scarred and unable to send oxygen to the brain and heart.
The Crown Princess has not undertaken any engagements since Jan. 28 ...
February 2026 coverage highlighted combination EGFR therapy guidance, chemo-free treatment options, biomarker testing and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results